Gongwin Biopharm Holdings Statistics

Total Valuation

TPEX:6617 has a market cap or net worth of TWD 12.79 billion. The enterprise value is 10.71 billion.

Market Cap	12.79B
Enterprise Value	10.71B

Important Dates

The last earnings date was Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6617 has 126.06 million shares outstanding. The number of shares has increased by 6.64% in one year.

Current Share Class	126.06M
Shares Outstanding	126.06M
Shares Change (YoY)	+6.64%
Shares Change (QoQ)	-0.51%
Owned by Insiders (%)	23.92%
Owned by Institutions (%)	0.04%
Float	58.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	373.85
PB Ratio	4.33
P/TBV Ratio	4.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-155.57
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-39.61

Financial Position

The company has a current ratio of 14.29, with a Debt / Equity ratio of 0.04.

Current Ratio	14.29
Quick Ratio	14.19
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.48
Interest Coverage	-35.14

Financial Efficiency

Return on equity (ROE) is -3.66% and return on invested capital (ROIC) is -4.52%.

Return on Equity (ROE)	-3.66%
Return on Assets (ROA)	-4.27%
Return on Invested Capital (ROIC)	-4.52%
Return on Capital Employed (ROCE)	-5.32%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	3.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.15% in the last 52 weeks. The beta is 0.60, so TPEX:6617's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-46.15%
50-Day Moving Average	94.89
200-Day Moving Average	110.06
Relative Strength Index (RSI)	60.51
Average Volume (20 Days)	190,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6617 had revenue of TWD 34.23 million and -68.82 million in losses. Loss per share was -0.55.

Revenue	34.23M
Gross Profit	10.93M
Operating Income	-162.33M
Pretax Income	-78.15M
Net Income	-68.82M
EBITDA	-152.09M
EBIT	-162.33M
Loss Per Share	-0.55

Full Income Statement

Balance Sheet

The company has 2.20 billion in cash and 130.59 million in debt, giving a net cash position of 2.07 billion or 16.42 per share.

Cash & Cash Equivalents	2.20B
Total Debt	130.59M
Net Cash	2.07B
Net Cash Per Share	16.42
Equity (Book Value)	2.95B
Book Value Per Share	22.73
Working Capital	2.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -84.66 million and capital expenditures -185.60 million, giving a free cash flow of -270.26 million.

Operating Cash Flow	-84.66M
Capital Expenditures	-185.60M
Free Cash Flow	-270.26M
FCF Per Share	-2.14

Full Cash Flow Statement

Margins

Gross margin is 31.92%, with operating and profit margins of -474.31% and -201.08%.

Gross Margin	31.92%
Operating Margin	-474.31%
Pretax Margin	-228.33%
Profit Margin	-201.08%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6617 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.64%
Shareholder Yield	-6.64%
Earnings Yield	-0.54%
FCF Yield	-2.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a